Arbutus Biopharma Corp
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -45.0% | -45.0% | -37.3% |
| FY2022 | -50.8% | -50.8% | -35.5% |
| FY2023 | -68.7% | -68.7% | -50.4% |
| FY2024 | -71.8% | -71.8% | -53.1% |
| FY2025 | -43.7% | -43.7% | -35.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -45.0% | -45.0% | -37.3% |
| FY2022 | -50.8% | -50.8% | -35.5% |
| FY2023 | -68.7% | -68.7% | -50.4% |
| FY2024 | -71.8% | -71.8% | -53.1% |
| FY2025 | -43.7% | -43.7% | -35.4% |